Scientists Develop Breakthrough Treatment Of Asbestos Linked Cancer
srh@bmcf.co.uk2024-02-26T14:20:56+00:00In a recent article published by The Guardian, it has been announced that a groundbreaking drug has been developed for treating mesothelioma, a cancer notoriously difficult to treat and linked to asbestos exposure. The drug, ADI-PEG20, was tested alongside chemotherapy in an international trial led by Queen Mary University of London. The article highlights results published in JAMA Oncology, which showed that the drug has the potential to quadruple the three-year survival rates, marking the most significant breakthrough in two decades for this aggressive and deadly cancer. The trial involved patients from five countries and demonstrated a significant increase in overall survival [...]









